Aspen Aerogels Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aspen Aerogels stock.
View analyst ratings for Aspen Aerogels or view top-rated stocks.

Wall Street analysts have given Aspen Aerogels a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aspen Aerogels wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Aspen Aerogels saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 510,900 shares, a drop of 28.7% from the August 15th total of 716,600 shares. Based on an average daily volume of 273,400 shares, the days-to-cover ratio is currently 1.9 days.
View Aspen Aerogels' Short Interest.

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Aspen Aerogels.

Aspen Aerogels, Inc. (NYSE:ASPN) posted its quarterly earnings results on Wednesday, July, 28th. The construction company reported ($0.23) EPS for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.04. The construction company had revenue of $31.67 million for the quarter, compared to analysts' expectations of $25.35 million. Aspen Aerogels had a negative net margin of 24.17% and a negative trailing twelve-month return on equity of 30.20%.
View Aspen Aerogels' earnings history.

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ASPN stock has increased by 580.3% and is now trading at $44.22.
View which stocks have been most impacted by COVID-19.

Aspen Aerogels issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $-1.040-$-0.940 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-1.010. The company issued revenue guidance of $110 million-$118 million, compared to the consensus revenue estimate of $109.37 million.

8 analysts have issued 12 month price targets for Aspen Aerogels' stock. Their forecasts range from $37.81 to $58.00. On average, they anticipate Aspen Aerogels' share price to reach $46.69 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price.
View analysts' price targets for Aspen Aerogels or view top-rated stocks among Wall Street analysts.

5 employees have rated Aspen Aerogels CEO Donald R. Young on Glassdoor.com. Donald R. Young has an approval rating of 100% among Aspen Aerogels' employees. This puts Donald R. Young in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Aspen Aerogels include Beacon Roofing Supply (BECN), Boise Cascade (BCC), GMS (GMS), Huttig Building Products (HBP) and SG Blocks (SGBX).
View all of ASPN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Gilead Sciences (GILD), Bank of America (BAC), AMC Entertainment (AMC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

Aspen Aerogels' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Jefferies Group LLC (0.00%), Spring Creek Capital LLC (10.51%), BlackRock Inc. (4.78%), Vanguard Group Inc. (3.96%), State Street Corp (2.24%) and Next Century Growth Investors LLC (1.81%). Company insiders that own Aspen Aerogels stock include Corby C Whitaker and Kelley Conte.
View institutional ownership trends for Aspen Aerogels.

ASPN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Morgan Stanley, Renaissance Technologies LLC, EAM Investors LLC, Roubaix Capital LLC, Price T Rowe Associates Inc. MD, and EAM Global Investors LLC. Company insiders that have sold Aspen Aerogels company stock in the last year include Corby C Whitaker, and Kelley Conte.
View insider buying and selling activity for Aspen Aerogels or view top insider-selling stocks.

ASPN stock was acquired by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Spring Creek Capital LLC, Cowen Prime Advisors LLC, Millennium Management LLC, RK Capital Management LLC, State Street Corp, Point72 Asset Management L.P., and Vanguard Group Inc..
View insider buying and selling activity for Aspen Aerogels or or view top insider-buying stocks.

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ASPN stock can currently be purchased for approximately $44.22.

Aspen Aerogels has a market capitalization of $1.46 billion and generates $100.27 million in revenue each year. The construction company earns $-21,810,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

Aspen Aerogels employs 290 workers across the globe.

The official website for Aspen Aerogels is www.aerogel.com.

Aspen Aerogels is headquartered at 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532.

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at (508) 691-1111 or via email at [email protected]